| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | DE19955803A1 Verwendung von Heparanase-Inhibitoren zur Behandlung von Hersinsuffizienz The use of heparanase inhibitors in the treatment of Hersinsuffizienz |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296492A Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296471A Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them |
| 05/23/2001 | CN1295843A Traditional Chinese Medicine for treating coronary heart disease and preparation method thereof |
| 05/23/2001 | CN1295834A Medicinal composition for treating proctoptoma |
| 05/23/2001 | CN1066246C Axial flow valve system for linear compressor |
| 05/23/2001 | CN1066146C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 05/23/2001 | CN1066138C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235923 Retinoids and cell differentiation |
| 05/22/2001 | US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 05/22/2001 | US6235909 Preparation of is-[1A,2B,3B,4A(S*)]-4-[7-[[1-(3-chloro-2-Thienyl)methyl]amino]-3H-imidazo [4,5-B]pyridin-3-YL]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide |
| 05/22/2001 | US6235778 Anticoagulants |
| 05/22/2001 | US6235770 Anticholesterol agents |
| 05/22/2001 | US6235767 Methods to treat arterial plaque |
| 05/22/2001 | US6235766 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 05/22/2001 | US6235760 Treatment for CNS injuries |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones |
| 05/22/2001 | US6235738 Brain disorders; antiischemic agents |
| 05/22/2001 | US6235730 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same |
| 05/22/2001 | US6235727 Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use |
| 05/22/2001 | US6235717 Pharmaceutical compounds |
| 05/22/2001 | US6235315 Solution of lycopene, solvent and emulsifier, mixing and removal of solvent to form dry powder |
| 05/22/2001 | US6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | CA2031937C Isomers of 1-azabicyclo¬2.2.2|oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001035106A2 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | WO2001034828A1 Process for producing tripeptides |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 05/17/2001 | WO2001034570A1 Nitrogenous heterocycle derivatives |
| 05/17/2001 | WO2001034562A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 05/17/2001 | WO2001034208A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034179A1 Method of inducing angiogenesis |
| 05/17/2001 | WO2001034141A1 Il-8 receptor antagonists |
| 05/17/2001 | WO2001034138A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | WO2001034136A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 05/17/2001 | WO2001034132A2 Use of an aldosterone antagonist for treating restenosis |
| 05/17/2001 | WO2001034127A1 Prevention of plaque rupture by acat inhibitors |
| 05/17/2001 | WO2001034088A2 Cardiac device for electrical and chemical regulation, and vasoactive intestinal peptide for treatment of cardiopulmonary disorders |
| 05/17/2001 | WO2001024796A8 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
| 05/17/2001 | WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001009116A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005810A3 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 05/17/2001 | WO2001005390A3 Method for treating chronic pain using mek inhibitors |
| 05/17/2001 | WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 05/17/2001 | WO2000076457A3 Il-8 receptor antagonists |
| 05/17/2001 | WO2000040613A9 Insulin-like growth factor (igf) i mutant variants |
| 05/17/2001 | WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 05/17/2001 | WO1999048536A3 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 05/17/2001 | DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor |
| 05/17/2001 | DE19953899A1 Carboxamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 05/17/2001 | CA2391448A1 Use of vasoactive intestinal peptides and kits therefor |
| 05/17/2001 | CA2390880A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 05/17/2001 | CA2390797A1 Methods for the treatment and prevention of neurodegenerative conditions |
| 05/17/2001 | CA2390655A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | CA2390561A1 Use of an aldosterone antagonist for treating restenosis |
| 05/17/2001 | CA2390524A1 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | CA2389954A1 Method of inducing angiogenesis |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |